The chairman Ingmar Haga and Interim CEO Marcus Ahlström have subscribed for or will subscribe for 650,000 shares in Endomines' rights issuePress release (PDF)
The information in this press release is not intended for distribution, publication or public release, directly or indirectly, in or into, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, Switzerland, the United States or any other jurisdiction where the publication or distribution of this press release may be unlawful. Please see the important notice at the end of this announcement.
Endomines AB, Stock Exchange Release, 25.6.2019 at 14:00 CEST
The subscription period for Endomines AB's rights issue runs between June 14, and July 1, 2019. Endomines’ chairman Ingmar Haga has subscribed for or will subscribe for 500,000 shares and the Interim CEO Marcus Ahlström has subscribed for 150,000 shares in the rights issue, which corresponds to issue proceeds of almost MSEK 2.3.
Some of the other existing shareholders have earlier signed subscription undertakings for approximately MSEK 16.5, representing 10 percent of the rights issue, while other shareholders have expressed their intention to subscribe for another approximately MSEK 33, representing 20 percent of the rights issue. The rights issue will upon full subscription provide Endomines with approximately MSEK 165 before deduction of transaction costs.
The Company have distributed an information folder to all shareholders with further instructions for subscription of shares in Sweden (in Swedish) and Finland (in Finnish). The information folder is available in Swedish, Finnish and English on Endomines website: www.endomines.se.
The prospectus, information brochures and subscription forms for subscription of shares in Sweden are available on the Company’s website, www.endomines.com and on Evli’s website, www.evli.com. For subscription of shares in Finland, shareholders and other investors are asked to follow instructions from their bank or other nominee. The printed prospectus is during the subscription period obtainable, free of charge, from Endomines, phone +46 (0)8 611 66 45, e-mail: email@example.com or Evli, phone +46 (0) 8 407 80 00, weekdays 9-16. Questions regarding the subscription and payment in both Finland and Sweden are answered by email: firstname.lastname@example.org and by phone as as mentioned above. Questions regarding the subscription and payment in Finland are answered by Evli, phone: +358 9 4766 9646, weekdays 9-16.
Marcus Ahlström, Interim CEO, +358 50 544 68 14, email@example.com
The information was submitted for publication, through the agency of the contact persons set out above, at 14:00 CEST on 25 June 2019.
Endomines is a mining and exploration company with its primary focus on gold. The Company explores for gold along the Karelian Gold Line in Eastern Finland and develops mining operations in Idaho, USA. Endomines aims to improve its long-term growth prospects by increasing its exploration activities and through acquisitions. Endomines aims to acquire deposits that are situated in stable jurisdictions and can be brought to production rapidly with limited investments.
The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).
The information in this press release does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Endomines. Any invitation to the persons concerned to subscribe for shares in Endomines is only made through the prospectus which Endomines made public on June 12, 2019.
This press release may not be released, published or distributed, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, Switzerland, the United States or any other jurisdiction where participation would require additional prospectuses, registration or measures besides those required by Swedish law. Nor may this press release be distributed in or into such countries or any other country or jurisdiction in which distribution requires such measures or otherwise would be in conflict with applicable regulations. Any failure to comply with the restrictions described may result in a violation of applicable securities regulations.
The subscription rights, paid subscribed shares and shares in Endomines have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and no subscription rights, paid subscribed shares or shares may be offered, subscribed for, exercised, pledged, sold, resold, granted, delivered or otherwise transferred, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States. There will be no public offering of such securities in the United States.
The securities referred to herein have not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the rights issue or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.
This press release contains certain forward-looking information that reflects Endomines’ present view of future events as well as financial and operational development. Words such as “intend”, “assess”, “expect”, “may”, “plan”, “believe”, “estimate” and other expressions entailing indications or predictions of future development or trends, not based on historical facts, constitute forward-looking information. Forward-looking information is inherently associated with both known and unknown risks and uncertainties as it depends on future events and circumstances. Forward-looking information is not a guarantee of future results or development and actual outcomes may differ materially from the statements set forth in the forward-looking information.
In case of differences between the Swedish, Finnish and English language versions of this press release, the Swedish language version shall prevail.